Catalent has announced it has completed the acquisition of Accucaps Industries, a Canada-based developer and manufacturer of Over-the-Counter (OTC), ...

JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...

Jupiter Neurosciences (JUNS) announced it has entered into an agreement with Catalent Pharma Solutions for the production of JOTROL softgel ...

Jupiter Neurosciences Inc., a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based platform, ...

The global softgel encapsulation machine market is poised for substantial growth over the next decade, with a projected valuation of USD 178.8 million by 2035. This represents a c ...

Patheon Inc is to launch the company’s capabilities at FCE Pharma in Sao Paulo, Brazil, 12-14 May 2014. Patheon ...